Production, Purification and Immunogenicity of a Malaria Transmission-Blocking Vaccine Candidate: TBV25H Expressed in Yeast and Purified Using Nickel-NTA Agarose

We have constructed a second generation malaria transmission-blocking vaccine candidate based on Pfs25, the predominate surface protein of Plasmodium falciparum zygotes, to overcome potential production problems with the original construct. Four modifications were made: (1) addition of the last cysteine residue of the fourth epidermal growth factor like-domain of Pfs25; (2) mutagenesis of asparagine-linked glycosylation sites with glutamine rather than alanine; (3) addition of a six histidine tag at the carboxy-terminus for highly efficient purification of recombinant protein on nickel-NTA agarose; and (4) fermentation that combines continuous glucose fed-batch methodology with pH-controlled glucose addition and a terminal ethanol feed. The resulting product, TBV25H (Transmission-Blocking Vaccine based on Pfs25 with a Histidine tag), appears to be a more potent antigen and immunogen than the original construct, and the fermentation and post-fermentation processing methodology easily lend themselves to technology transfer to the ultimate users, newly industrialized countries.

References

  1. 1

    Oaks, S.C., Mitchell, V.S., Pearson, G.W. and Carpenter, C.C.I. (Eds.) 1991. Malaria: Obstacles and opportunities: A report of the Committee for the Study on Malaria Prevention and Control. National Academy Press, Washington, D.C.

  2. 2

    Kaslow, D.C. 1993. Transmission-blocking immunity against malaria and other vector-borne diseases. Curr. Opinion in Immunol. 5: 557–565.

    CAS  Article  Google Scholar 

  3. 3

    Kaslow, D.C., Quakyi, I.A., Syin, C., Raum, M.G., Keister, D.B., Coligan, J.E., McCutchan, T.F. and Miller, L.H. 1988. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 333: 74–76.

    CAS  Article  Google Scholar 

  4. 4

    Kaslow, D.C., Isaacs, S., Quakyi, I.A., Gwadz, R.W., Moss, B. and Keister, D.B. 1991. Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. Science 252: 1310–1313.

    CAS  Article  Google Scholar 

  5. 5

    Barr, P.J., Green, K.M., Gibson, H.L., Bathurst, I.C., Quakyi, I.A. and Kaslow, D.C. 1991. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J. Exp. Med. 174: 1203–1208.

    CAS  Article  Google Scholar 

  6. 6

    Kaslow, D.C., Bathurst, I.C., Keister, D.B., Campbell, G.H., Adams, S., Morris, C.L., Sullivan, J.S., Barr, P.J. and Collins, W.E. 1993. Safety, immunogenicity and in vitro efficacy of a muramyl tripeptide-based malaria transmission-blocking vaccine in an Aotus nancymai monkey model. Vaccine Res. 2: 95–103.

    Google Scholar 

  7. 7

    Price, V., Mochizuki, D., March, C.J., Cosman, D., Deeley, M.C., Klinke, R., Clevenger, W., Gillis, S., Baker, P. and Urdal, D. 1987. Expression, purification and characterization of recombinant murine granulocyte-macrophage colony-stimulating factor and bovine interleukin-2 from yeast. Gene 55: 287–293.

    CAS  Article  Google Scholar 

  8. 8

    Crowe, J. and Henco, K. 1992. The QIA expressionist. QIAGEN, Inc. Chats-worth, California.

    Google Scholar 

  9. 9

    Tøttrup, H.V. and Carlsen, S. 1990. A process for the production of human proinsulin in Saccharomyces cerevisiae. Biotech. Bioeng. 35: 339–348.

    Article  Google Scholar 

  10. 10

    Porro, D., Martegani, E., Tura, E. and Ranzi, B.M. 1991. Development of a pH-controlled fed-batch system for budding yeast. Res. Microbiol. 142: 535–539.

    CAS  Article  Google Scholar 

  11. 11

    Hochuli, E., Barnsworth, W., Döbeli, H., Gentz, R. and Sfuber, D. 1988. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Bio/Technology 6: 1321–1325.

    CAS  Google Scholar 

  12. 12

    O'Shannessy, D.J., Voorstad, P.J. and Quarles, R.H. 1987. Quantitation of glycoproteins on electroblots using the biotin-streptavidin complex. Anal. Biochem. 163: 204–209.

    CAS  Article  Google Scholar 

  13. 13

    Hancock, K. and Tsang, V.C.W. 1986. Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni. J. Immunol. Methods 92: 167–176.

    CAS  Article  Google Scholar 

  14. 14

    Quakyi, I.A., Carter, R., Rener, J., Kumar, N., Good, M.F. and Miler, L.H. 1987. The 230-kD gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J. Immunol. 139: 4213–4217.

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to David C. Kaslow.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kaslow, D., Shiloach, J. Production, Purification and Immunogenicity of a Malaria Transmission-Blocking Vaccine Candidate: TBV25H Expressed in Yeast and Purified Using Nickel-NTA Agarose. Nat Biotechnol 12, 494–499 (1994). https://doi.org/10.1038/nbt0594-494

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing